[Federal Register Volume 79, Number 91 (Monday, May 12, 2014)]
[Notices]
[Page 26954]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-10754]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Intent To Grant an Exclusive License of U.S. Government-Owned 
Patent

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i), 
announcement is made of the intent to grant an exclusive, royalty-
bearing, revocable license to PCT Application PCT/2013/040641 filed May 
10, 2013, entitled ``Toxin Detection Using Stem Cell Derived Neurons'' 
to SynActive Bioscience, LLC, with its principal place of business at 
813 S. Rose Street, Baltimore, MD 21224.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For licensing issues, Dr. Paul Mele, 
Office of Research & Technology Assessment, (301) 619-6664. For patent 
issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808, both at 
telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: Anyone wishing to object to grant of this 
license can file written objections along with supporting evidence, if 
any, within 15 days from the date of this publication. Written 
objections are to be filed with the Command Judge Advocate (see 
ADDRESSES).

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2014-10754 Filed 5-9-14; 8:45 am]
BILLING CODE 3710-08-P